Siga Technologies (SIGA) EBITDA Margin Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Siga Technologies | 214.01 Mn | 59.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -44,955.00 |
| Jun 30, 2025 | 3,789.00 |
| Mar 31, 2025 | -1,838.00 |
| Dec 31, 2024 | -1,144.00 |
| Sep 30, 2024 | 6,616.00 |
| Jun 30, 2024 | 494.00 |
| Mar 31, 2024 | 8,567.00 |
| Dec 31, 2023 | 766.00 |
| Sep 30, 2023 | -8,850.00 |
| Jun 30, 2023 | -15,028.00 |
| Mar 31, 2023 | 12,728.00 |
| Dec 31, 2022 | 6,549.00 |
| Sep 30, 2022 | 5,123.00 |
| Jun 30, 2022 | 6,206.00 |
| Mar 31, 2022 | -3,461.00 |
| Dec 31, 2021 | 43,466.00 |
| Sep 30, 2021 | -13,905.00 |
| Jun 30, 2021 | 13,943.00 |
| Mar 31, 2021 | 21,811.00 |
| Dec 31, 2020 | 41,601.00 |